|
Press Releases
January 17, 2012
NOVELOS THERAPEUTICS ENROLLS FIRST PATIENT IN PHASE 1b TRIAL IN
SOLID TUMORS WITH I-131-CLR1404 (HOT) CANCER-TARGETED MOLECULAR
RADIOTHERAPEUTIC
Click for press release
December 7, 2011
NOVELOS
THERAPEUTICS CLOSES $6 MILLION PUBLIC OFFERING
Click for press release
December 1, 2011
NOVELOS
THERAPEUTICS PRICES $5.9 MILLION PUBLIC OFFERING
Click for press release
October 19, 2011
NOVELOS
THERAPEUTICS ANNOUNCES JUDGMENT IN ITS FAVOR AND DISMISSAL OF STATE LAW
COUNTERCLAIMS
Click for press release
September 6, 2011
NOVELOS THERAPEUTICS TO PRESENT AT RODMAN & RENSHAW 13th ANNUAL
HEALTHCARE CONFERENCE ON SEPTEMBER 12
Click for press release
June 28, 2011
NOVELOS
THERAPEUTICS ANNOUNCES DISMISSAL OF PUTATIVE FEDERAL SECURITIES CLASS
ACTION LAWSUIT
Click for press release
June 13, 2011
NOVELOS
THERAPEUTICS TO PRESENT AT THE 5th LIPPERT/HEILSHORN LIFE SCIENCES &
MEDICAL TECHNOLOGIES VIRTUAL CONFERENCE ON JUNE 16
Click for
press release
May 9, 2011
NOVELOS
THERAPEUTICS TRADING SYMBOL REVERTS TO NVLT
Click for press
release
April 26, 2011
NOVELOS
THERAPEUTICS WELCOMES FIVE NEW DIRECTORS
Click for
press release
April 11, 2011
NOVELOS
THERAPEUTICS COMPLETES ACQUISITION AND $5.1 MILLION FINANCING TO DEVELOP 3
NOVEL CANCER-TARGETED COMPOUNDS
Click for press release
Archived PRs
2005-2010 |